Intraocular pressure in the adult population of Arkhangelsk and its associations with socio-demographic characteristics, lifestyle, and general health status

Abstract

Background: Glaucoma is considered one of the leading causes of disability. Intraocular pressure is a key risk factor for the development of glaucoma, which underscores the importance of its assessment and control. The pneumotonometric method for measuring intraocular pressure is being widely used in glaucoma screening diagnostics.

Aim: The work aimed to determine population-based reference values and age-related changes in intraocular pressure among adults in the European North of Russia and to examine associations between intraocular pressure and socio-demographic characteristics, lifestyle factors, and health indicators.

Methods: A random sample of Arkhangelsk residents aged 45–74 years (n = 1223) was examined, including an ophthalmologic assessment and pneumotonometry. Socio-demographic and lifestyle data were collected via face-to-face interviews, and health characteristics were obtained through clinical examinations. Reference intraocular pressure values were defined using the 5th and 95th percentiles. Associations between intraocular pressure and study variables were assessed using multivariable linear regression and presented as B coefficients with 95% confidence intervals (CI).

Results: The mean intraocular pressure was 14.2 mmHg overall, 13.9 mmHg in men, and 14.4 mmHg in women. Population-based reference ranges for true intraocular pressure were identified as follows: low-normal (9–12 mmHg), mid-normal (12–16 mmHg), and high-normal (16–20 mmHg). Intraocular pressure levels showed a downward trend with increasing age in both women (p = 0.007) and men (p = 0.011). Inverse associations were found between intraocular pressure and male sex (B = –0.56; 95% CI: –0.94 to –0.18), indigenous status in the Arkhangelsk Region (B = –0.50; 95% CI: –0.83 to –0.16), and higher education (B = –0.40; 95% CI: –0.73 to –0.06). Among health-related variables, intraocular pressure was associated with hypertension (B = 0.56; 95% CI: 0.17 to 0.94), diabetes mellitus (B = 0.46; 95% CI: 0.03 to 0.89), dyslipidemia (B = 0.36; 95% CI: 0.01 to 0.71), abdominal obesity (B = 0.39; 95% CI: 0.31 to 0.98), thyroid dysfunction (B = 0.42; 95% CI: 0.07 to 0.77), vitamin D deficiency (B = 0.76; 95% CI: 0.30 to 1.22), and low serum total protein (B = –0.76; 95% CI: –1.43 to –0.09).

Conclusion: This study established normal intraocular pressure ranges for residents of the European North of Russia aged 45–74 years. A decrease in intraocular pressure with age was observed, along with lower intraocular pressure levels in men, indigenous residents of the Arkhangelsk Region, and individuals with low serum protein. Elevated intraocular pressure levels were associated with hypertension, diabetes mellitus, dyslipidemia, obesity, thyroid dysfunction, and vitamin D deficiency.

About the authors

Maria A. Sinayskaya

Northern State Medical University

Email: msinayskaya@inbox.ru
ORCID iD: 0009-0009-6587-7149
SPIN-code: 1709-6124

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

Roman N. Zelentsov

Northern State Medical University

Author for correspondence.
Email: zelentsovrn@gmail.com
ORCID iD: 0000-0002-4875-0535
SPIN-code: 9312-3211

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

Natalya A. Bebyakova

Northern State Medical University

Email: nbebyakova@mail.ru
ORCID iD: 0000-0002-9346-1898
SPIN-code: 6326-5523

Dr. Sci (Biology), Professor

Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

Natalia I. Pechinkina

Northern State Medical University

Email: belova-8@mail.ru
ORCID iD: 0000-0001-9066-5687
SPIN-code: 5164-4187
Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

Anastasia A. Trofimova

Northern State Medical University

Email: aa.trofimova@mail.ru
ORCID iD: 0000-0002-2248-6991
SPIN-code: 8388-3638
Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

Alexander V. Kudryavtsev

Northern State Medical University

Email: alex.v.kudryavtsev@yandex.ru
ORCID iD: 0000-0001-8902-8947
SPIN-code: 9296-2930

Ph.D.

Russian Federation, 51 Troitskiy аve, Arkhangelsk, 163069

References

  1. Tham YC, Li X, Wong TY, et al. Global Prevalence of Glaucoma and Projections of Glaucoma Burden Through 2040: A Systematic Review and Meta-Analysis. Ophthalmology. 2014;121(11):2081-2090. doi: 10.1016/j.ophtha.2014.05.013
  2. Terminology and Guidelines for Glaucoma: European Glaucoma society.4th Edition. Savona, Italy; 2014.
  3. National guidance on glaucoma: for practitioners/ under the editorship of professor EA Egorov, professor YuS Astakhov, professor VP Erichev. Moscow: GEOTAR-Media; 2015. 456 p. (in Russ.)
  4. David R, Zangwill L, Stone D, Yassur Y. Epidemiology of Intraocular Pressure in a Population Screened for Glaucoma. Br. J. Ophthalmol. 1987;71(10):766-771. doi: 10.1136/bjo.71.10.766
  5. Fukuoka S, Aihara M, Iwase A, Araie M. Intraocular Pressure in an Ophthalmologically Normal Japanese Population. Acta Ophthalmol. 2008;86(4):434-439. doi: 10.1111/j.1600-0420.2007.01068.x
  6. Vijaya L, George R, Arvind H, et al. Central Corneal Thickness in Adult South Indians: The Chennai Glaucoma Study. Ophthalmology. 2010; 117(4):700-704. doi: 10.1016/j.ophtha.2009.09.025
  7. Xu L, Li J, Zheng Y, et al. Intraocular Pressure in Northern China in an Urban and Rural Population: the Beijing Eye Study. Am. J. Ophthalmol. 2005;140(5):913-915. doi: 10.1016/j.ajo.2005.04.050
  8. Onishchenko AL, Kolbasko AV, Shirina MA. Vnutriglaznoe Davlenie u Tubalarov — Korennogo Naseleniya Respubliki Altaj. Glaukoma. 2011; 4:49-51.
  9. Baboolal SO, Smit DP South African Eye Study (SAES): Ethnic Differences in Central Corneal Thickness and Intraocular Pressure. Eye (London, U. K.). 2018;32(4):749-756. doi: 10.1038/eye.2017.291
  10. Klein BE, Klein R, Linton KL. Intraocular Pressure in an American Community. The Beaver Dam Eye Study. Invest. Ophthalmol. Visual Sci. 1992;33(7):2224-2228. PMID: 1607232
  11. Wu SY, Leske MC. Associations With Intraocular Pressure in the Barbados Eye Study. Arch. Ophthalmol. 1997;115(12):1572-1576. doi: 10.1001/archopht.1997.01100160742012
  12. Lee MK, Cho SI, Kim H., et al. Epidemiologic Characteristics of Intraocular Pressure in the Korean and Mongolian Populations: the Healthy Twin and the GENDISCAN Study. Ophthalmology. 2012;119(3):450-457. doi: 10.1016/j.ophtha.2011.09.016
  13. Lin HY, Hsu WM, Chou P, et al. Intraocular Pressure Measured With a Noncontact Tonometer in an Elderly Chinese Population: The Shihpai Eye Study. Arch. Ophthalmol. 2005;123(3):381-386. doi: 10.1001/archopht.123.3.381
  14. Mori K, Ando F, Nomura H, et al. Relationship Between Intraocular Pressure and Obesity in Japan. Int. J. Epidemiol. 2000;29(4):661-666. doi: 10.1093/ije/29.4.661 EDN: IQCDEV
  15. Lee JS, Lee SH, Oum BS, et al. Relationship Between Intraocular Pressure and Systemic Health Parameters in a Korean Population. Graefe's Arch. Clin. Exp. Ophthalmol.. 2002;30(4):237-241. doi: 10.1046/j.1442-9071.2002.00527.x EDN: BADWYT
  16. Carel RS, Korczyn AD, Rock M, Goya I. Association Between Ocular Pressure and Certain Health Parameters. Am. J. Ophthalmol.. 1984;91(4):311-314. doi: 10.1016/S0161-6420(84)34282-8
  17. Levitsky SN, Bebyakova NA, Pechinkina NI, et al. Polymorphism of Genes Involved in the Regulation of Blood Pressure in Elderly Residents of the Arkhangelsk Region. Ekologiya cheloveka (Human Ecology). 2024;31(3):233–246 doi: 10.17816/humeco633999 EDN: QYDTVN
  18. Neufeld M, Rehm J, Bunova A, et al.; The 2019/2020 RUS-AUDIT Collaborators & the RUS-AUDIT Project Advisory Board. Validation of a Screening Test for Alcohol Use, the Russian Federation. Bull. W. H. O. 2021;99:496-505. doi: 10.2471/BLT.20.273227 EDN: KWLLPF
  19. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 2021;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309 EDN: DGYBZW
  20. Maklakov AN. Eshche po Povodu Oftal'motonometrii. Hirurgicheskaya letopis'. 1893;4:1-11. (In Russ.)
  21. Mel'nik LS. O Normah Elastotonometricheskih Krivyh. Oftal'mologicheskij zhurnal. 1961;16(4):221. (In Russ.)
  22. Nesterov AP, Cherkunov BF. Elastotonometricheskie Issledovaniya Normal'nyh Glaz. Sb. nauch. tr. Kafedra glaznyh boleznej Kujbyshevskogo medinstituta. Kujbyshev; 1963:97-99. (In Russ.)
  23. Belorussov VK. O Normah Elastotonometricheskih Krivyh u Lic Raznyh Vozrastnyh Kategorij. Oftal'mologicheskij zhurnal. 1964;19(5):326-331. (In Russ.)
  24. Panina NB. O Normah Vnutriglaznogo Davleniya. Glaukoma i Drugie Zabolevaniya Glaz. Leningrad, 1971: 7-12. (In Russ.)
  25. Alekseev VN, Egorov EA, Martynova EB. O Raspredelenii Urovnej Vnutriglaznogo Davleniya v Normal'noj Populyacii. RMZh. Klinicheskaya oftal'mologiya. 2001;2(2):38-40. Available from: https://www.rmj.ru/articles/oftalmologiya/O_raspredelenii_urovney_vnutriglaznogo_davleniya_v_normalynoy_populyacii/?ysclid=mcg2sc6j3r26372234
  26. Egorov EA, Petrov SYu, Gorodnichij VV, Kuroedov AV, i dr. Tonometricheskoe vnutriglaznoe davlenie u vzroslogo naseleniya: populyacionnoe issledovanie. Nacional'nyj zhurnal glaukoma. 2020;19(2):39-50.
  27. Egorov EA, Erichev VP, Kuroedov AV, et al. Tonometric Intraocular Pressure Reference Values In Healthy Population. Nacional'nyj zhurnal glaukoma. 2018;17(2):91-98. doi: 10.25700/NJG.2018.02.09 EDN: UTLYOF
  28. Chan MP, Grossi CM, Khawaja AP, et al., UK Biobank Eye and Vision Consortium. Associations with Intraocular Pressure in a Large Cohort: Results from the UK Biobank. Ophthalmology. 2016;123(4):771-782. doi: 10.1016/j.ophtha.2015.11.031
  29. Leske MC, Connell AM, Wu SY, et al. Distribution of Intraocular Pressure. The Barbados Eye Study. Arch. Ophthalmol. 1997;115(8):1051-1057. doi: 10.1001/archopht.1997.01100160221012
  30. Han X, Niu Y, Guo X, et al. Age-Related Changes of Intraocular Pressure in Elderly People in Southern China: Lingtou Eye Cohort Study. PLoS One. 2016;11(3):e0151766. doi: 10.1371/journal.pone.0151766
  31. Bikbov MM, Kazakbaeva GM, Zainullin RM, et al. Intraocular Pressure and its Associations in a Russian Population: The Ural Eye and Medical Study. Am. J. Ophthalmol. 2019;204:130-139. doi: 10.1016/j.ajo.2019.02.030 EDN: LRJTCU
  32. Kim MJ, Park KH, Kim CY, et al. The Distribution of Intraocular Pressure and Associated systemic Factors in a Korean Population: The Korea National Health and Nutrition Examination Survey. Acta Ophthalmol. 2014;92(7):e507-513. doi: 10.1111/aos.12327
  33. Pakravan M, Javadi MA, Yazdani S, et al. Distribution of Intraocular Pressure, Central Corneal Thickness and Vertical Cup-to-Disc Ratio in a Healthy Iranian Population: The Yazd Eye Study. Acta Ophthalmol. 2017; 95(2):e144-e151. doi: 10.1111/aos.13231
  34. Landers J, Henderson T, Craig J. Distribution and Associations of Intraocular Pressure in Indigenous Australians within central Australia: The Central Australian Ocular Health Study. Clin. Exp. Ophthalmol. 2011; 39(7):607-613. doi: 10.1111/j.1442-9071.2011.02507.x
  35. Lantukh BB. Primary Glaucoma in the Indigenous Population of the Far North. Vestn. Ophthtalmol. 1985;1:60-62. (In Russ.) PMID: 3885552.
  36. Charaf W.M., , Siplivy V.I. Epidemiological aspects of glaucoma clinical progression,depending on social, economic, ethnic and geographic factors. Nacional'nyj zhurnal Glaukoma. 2014;13(1):68-76. EDN: SJVMTP
  37. Kiseleva OA, Robustova OV, Bessmertny AM, et al. Prevalence of primary glaucoma in representatives of different races and ethnic groups in Russia and in CIS. Oftal'mologiya. 2013;10(4):11-15. doi: 10.18008/1816-5095-2013-4-11-15
  38. Memarzadeh F, Ying-Lai M, Azen SP, Varma R, The Los Angeles Latino Eye Study Group. Associations with Intraocular Pressure in Latinos: The Los Angeles Latino Eye Study. Am. J. Ophthalmol. 2008;146(1):69-76. doi: 10.1016/j.ajo.2008.03.015
  39. Chumakova G.A., Kuznetsova T.Yu., Druzhilov M.A. Diversity of hypertension in obesity. Russian Journal of Cardiology. 2023;28(4):5360. doi: 10.15829/1560-4071-2023-5360 EDN: KJDGWY
  40. Khawaja AP, Springelkamp H, Creuzot-Garcher C, et al., The European Eye Epidemiology C. Associations with Intraocular Pressure Across Europe: The European Eye Epidemiology (E3) Consortium. Eur. J. Epidemiol. 2016;31(11):1101-1111. doi: 10.1007/s10654-016-0191-1 EDN: YWCLYL
  41. Cui Y, Yang X, Zhang G, et al. Intraocular Pressure in General and Diabetic Populations From Southern China: The Dongguan Eye Study. Invest. Ophthalmol. Visual Sci. 2019;60(2):761-769. doi: 10.1167/iovs.18-25247
  42. Hoehn R, Mirshahi A, Hoffmann EM, et al. Distribution of Intraocular Pressure and Its Association with Ocular Features and Cardiovascular Risk Factors: The Gutenberg Health Study. Ophthalmology. 2013;120(5):961-968. doi: 10.1016/j.ophtha.2012.10.031
  43. Qureshi IA. Intraocular pressure: a comparative analysis in two sexes. Clin. Physiol. 1997;17(3):247–255. doi: 10.1111/j.1365-2281.1997.tb00004.x
  44. Hashemi H, Khabazkhoob M, Emamian MH, et al. Distribution of Intraocular Pressure and Its Determinants in an Iranian Adult Population. Int. J. Ophthalmol. 2016;9(8):1207-1214. doi: 10.18240/ijo.2016.08.19
  45. Foster PJ, Machin D, Wong TY, et al. Determinants of Intraocular Pressure and Its Association with Glaucomatous Optic Neuropathy in Chinese Singaporeans: the Tanjong Pagar Study. Invest. Ophthalmol. Visual Sci. 2003;44(9):3885-91. doi: 10.1167/iovs.03-0012
  46. Rochtchina E, Mitchell P, Wang JJ. Relationship Between Age and Intraocular Pressure: the Blue Mountains Eye Study. Graefe's Arch. Clin. Exp. Ophthalmol. 2002;30(3):173-175. doi: 10.1046/j.1442-9071.2002.00519.x EDN: BADWVR
  47. Klein BE, Klein R. Intraocular Pressure and Cardiovascular Risk Variables. Arch. Ophthalmol. 1981;99(5):837-839. doi: 10.1001/archopht.1981.03930010837009
  48. Leske MC, Podgor MJ. Intraocular Pressure, Cardiovascular Risk Variables, and Visual Field Defects. Am. J. Epidemiol. 1983;118(2):280-287. doi: 10.1093/oxfordjournals.aje.a113634 EDN: IKJJYT
  49. Chumakova GA, Kuznecova TYu, Druzhilov MA., Veselovskaya NG. Obesity induced hypertension: The main pathophysiological mechanisms. Arterial'naya gipertenziya (Arterial Hypertension). 2021;27(3):260-268. doi: 10.18705/1607-419X-2021-27-3-260-268 EDN: OEYVXU
  50. Demidova TYu, Grickevich EYu. Obesity and Arterial Hypertension: Mechanisms and Possibilities of Therapy. FOCUS. Endokrinologiya. 2020;1(1):52-59. doi: 10.47407/ef2020.1.1.0007 EDN: LJFDXC
  51. Boyarinova MA., Rotar' OP, Konradi AO. Adipokines and Cardiometabolic Syndrome. Arterial'naya gipertenziya (Arterial Hypertension). 2014;20(5):422-432. doi: 10.18705/1607-419X2014-20-5-422-432 EDN: TAIGXD
  52. Wagner J, Danser AHJ, Derkx FH. et al. Demonstration of Renin mRNA, Angiotensinogen mRNA, and Angiotensin Converting Enzyme mRNA Expression in the Human Eye: Evidence for an Intraocular Renin-angiotensin System. Br. J. Ophthalmol. – 1996;80(2):159-163. doi: 10.1136/bjo.80.2.159
  53. Murata M, Nakagawa M, Takahashi S. Expression and Localisation of Angiotensin II Type 1 Receptor mRNA in Rat Ocular Tissues. Ophtalmologica. 1997;211(6):384-386. doi: 10.1159/000310835
  54. Shestakova MV. The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications. Saharnyj diabet (Diabetes mellitus). 2010;13(3):14-19. (In Russ.)doi: 10.14341/2072-0351-5481 EDN: NDKACL
  55. Likhvantseva VG, Korosteleva EV, Kovelenova IV, et al. Eye blood flow deficiency is the key factor determining the form of the secondary glaucoma in endocrine ophthalmopath. Russian Ophthalmological Journal. 2016;9(3):43-49. doi: 10.21516/2072-0076-2016-9-3-43-49
  56. Likhvantseva VG, Korosteleva EV, Tabeyeva KI, Vygodin VA. The Associative Link Between Thyroid Gland Diseases And Primary Open-Angle Glaucoma. Glaukoma. 2013;2:19-22. EDN: RSNOLV
  57. Cross JM, Girkin CA, Owsley C, McGwin G. The Association Between Thyroid Problems and Glaucoma. PLoS One. 2015;10(7): e0133688
  58. Lee AJ, Rochtchina E., Wang JJ, et al. Open-angle glaucoma and systemic thyroid disease in an older population: The Blue Mountains Eye Study. Eye (Lond). – 2004;18:600-608. doi: 10.1038/sj.eye.670073
  59. Kakigi C, Kasuga T, Wang Y, et al. Hypothyroidism and Glaucoma in The United States. PLoS One. 2015;10(7): e0133688. doi: 10.1371/journal.pone.0133688
  60. Karadimas P, Bouzas EA, Topouzis F, et al. Hypothyroidism and glaucoma. A study of 100 hypothyroid patients. Am. J. Ophthalmol. 2001;131:126-128. doi: 10.1016/s0002-9394(00)00724-8
  61. Motsko SP, Jones JK. Is There an Association between Hypothyroidism and Open-Angle Glaucoma in an Elderly Population? An Epidemiologic Study. Ophthalmology. 2008;115(9):1581-1584. doi: 10.1016/j.ophtha.2008.01.016
  62. Duncan KG, Jumper MD, Ribeiro RC, et al. Human Trabecular Meshwork Cells as a Thyroid Hormone Target Tissue: Presence of Functional Thyroid Hormone Receptors. Graefe's Arch/ Clin. Exp. Ophthalmol. 1999;237:231-240. doi: 10.1007/s004170050224
  63. Smith KD, Arthurs BP, Saheb N. An Association between Hypothyroidism and Primary Open-Angle Glaucoma. Ophthalmology. .1993;100(10):1580-1584. doi: 10.1016/S0161-6420(93)31441-7
  64. Beletskaya IS, Karonova TL, Astakhov S.Y. 25-Hydroxyvitamin D and matrix metalloproteinases-2, -9 level in patients with primary open angle glaucoma and pseudoexfoliative glaucoma/syndrome. Ophthalmology Reports. 2017;T(1):10-16. doi: 10.17816/OV10110-16 EDN: YNAGQF
  65. Yoo TK, Oh E, Hong S. Is Vitamin D Status Associated with Open-angle Glaucoma? A Cross-Sectional Study from South Korea. Public Health Nutr. 2014;17(4):833-843. doi: 10.1017/S1368980013003492
  66. Goncalves A, Milea D, Gohier P, et al. Serum Vitamin D Status Is Associated with the Presence But Not the Severity оf Primary Open Angle Glaucoma. Maturitas. 2015;81(4):470-474. doi: 10.1016/j.maturitas.2015.05.008
  67. Pigarova EA, Rozhinskaya L.Ya., Belaya J.E., et al. Russian Association of Endocrinologists Recommendations for Diagnosis, Treatment and Prevention of Vitamin D Deficiency in Adults. Problems of Endocrinology. 2016;62(4):60-84. doi: 10.14341/probl201662460-84 EDN: WMZICF
  68. Garcion E, Sindji L, Nataf S, et al. Treatment of Experimental AutoImmune Encephalomyelitis In Rat by 1,25-Dihydroxyvitamin D3 Leads to Early Effects Within the Central Nervous System. Acta Neuropathol. 2003;105:438-448. doi: 10.1007/s00401-002-0663-0 EDN: ESHQJN
  69. Kutuzova GD, Gabelt BT, Kiland JA, et al. 1α,25-Dihydroxyvitamin D3 and Its Analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 (2MD), Suppress Intraocular Pressure in Non-human Primates. Arch. Biochem. Biophys. 2012;518(1):53-60. doi: 10.1016/j.abb.2011.10.022
  70. Yin Z, Pintea V, Lin Y, et al. Vitamin D enhances corneal epithelial barrier function. Invest. Ophthalmol. Visual Sci. 2011;52(10):7359-7364. doi: 10.1167/iovs.11-7605
  71. Lin Y, Ubels JL, Schotanus MP, et al. Enhancement of Vitamin D Metabolites in the Eye Following Vitamin D3 Supplementation and UV-B Irradiation. Curr. Eye Res. 2012;37(10):871-878. doi: 10.3109/02713683.2012.688235
  72. Alsalem JA, Patel D, Susarla R, et al. Characterization of Vitamin D Production by Human Ocular Barrier Cells. Invest. Ophthalmol. Visual Sci. 2014;55(4):2140-2147. doi: 10.1167/iovs.13-13019
  73. Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium. 2011;50(3):211-221. doi: 10.1016/j.ceca.2011.03.003 EDN: PDZTPH
  74. Beletskaya IS, Astakhov SY, Karonova TL, et al. Pseudoexfoliative glaucoma and molecular genetic characteristics of vitamin D metabolism. Ophthalmology Reports. 2018;11(2):19-28. doi: 10.17816/OV11219-28 EDN: XQCJWP

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Distribution of intraocular pressure values (mmHg) in male and female eyes, aged 45–74 years, residents of Arkhangelsk.

Download (243KB)
3. Fig. 2. Mean intraocular pressure in men and women across 5-year age groups within the 45–74-year range, residents of Arkhangelsk (1552 eyes).

Download (162KB)

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».